Quản lý tăng bilirubin máu ở trẻ sơ sinh đủ tháng (35 tuần tuổi thai trở lên)
Tóm tắt
Từ khóa
#tăng bilirubin máu #trẻ sơ sinh #vàng da #quang trị liệu #kernicterus #bệnh não do bilirubin #tuần tuổi thai #phòng ngừa #quản lý #đánh giá nguy cơTài liệu tham khảo
American Academy of Pediatrics, Provisional Committee for Quality Improvement and Subcommittee on Hyperbilirubinemia. Practice parameter: management of hyperbilirubinemia in the healthy term newborn. Pediatrics. 1994;94:558–562
Ip S, Glicken S, Kulig J, Obrien R, Sege R, Lau J. Management of Neonatal Hyperbilirubinemia. Rockville, MD: US Department of Health and Human Services, Agency for Healthcare Research and Quality; 2003. AHRQ Publication 03-E011
Ip S, Chung M, Kulig J. et al. An evidence-based review of important issues concerning neonatal hyperbilirubinemia. Pediatrics. 2004;113(6). Available at: www.pediatrics.org/cgi/content/full/113/6/e644
American Academy of Pediatrics, Steering Committee on Quality Improvement and Management. A taxonomy of recommendations. Pediatrics. 2004; In press
Johnson LH, Bhutani VK, Brown AK. System-based approach to management of neonatal jaundice and prevention of kernicterus. J Pediatr. 2002;140:396–403
Maisels MJ, Newman TB. Kernicterus in otherwise healthy, breast-fed term newborns. Pediatrics. 1995;96:730–733
MacDonald M. Hidden risks: early discharge and bilirubin toxicity due to glucose-6-phosphate dehydrogenase deficiency. Pediatrics. 1995;96:734–738
Penn AA, Enzman DR, Hahn JS, Stevenson DK. Kernicterus in a full term infant. Pediatrics. 1994;93:1003–1006
Washington EC, Ector W, Abboud M, Ohning B, Holden K. Hemolytic jaundice due to G6PD deficiency causing kernicterus in a female newborn. South Med J. 1995;88:776–779
Ebbesen F. Recurrence of kernicterus in term and near-term infants in Denmark. Acta Paediatr. 2000;89:1213–1217
Institue of Medicine. Crossing the Quality Chasm: A New Health System for the 21st Century. Washington, DC: National Academy Press; 2001
American Academy of Pediatrics, American College of Obstetricians and Gynecologists. Guidelines for Perinatal Care. 5th ed. Elk Grove Village, IL: American Academy of Pediatrics; 2002:220–224
Bertini G, Dani C, Trochin M, Rubaltelli F. Is breastfeeding really favoring early neonatal jaundice?Pediatrics. 2001;107(3). Available at: www.pediatrics.org/cgi/content/full/107/3/e41
Maisels MJ, Gifford K. Normal serum bilirubin levels in the newborn and the effect of breast-feeding. Pediatrics. 1986;78:837–843
Yamauchi Y, Yamanouchi I. Breast-feeding frequency during the first 24 hours after birth in full-term neonates. Pediatrics. 1990;86:171–175
De Carvalho M, Klaus MH, Merkatz RB. Frequency of breastfeeding and serum bilirubin concentration. Am J Dis Child. 1982;136:737–738
Varimo P, Similä S, Wendt L, Kolvisto M. Frequency of breast feeding and hyperbilirubinemia [letter]. Clin Pediatr (Phila). 1986;25:112
De Carvalho M, Holl M, Harvey D. Effects of water supplementation on physiological jaundice in breast-fed babies. Arch Dis Child. 1981;56:568–569
Nicoll A, Ginsburg R, Tripp JH. Supplementary feeding and jaundice in newborns. Acta Paediatr Scand. 1982;71:759–761
Madlon-Kay DJ. Identifying ABO incompatibility in newborns: selective vs automatic testing. J Fam Pract. 1992;35:278–280
Moyer VA, Ahn C, Sneed S. Accuracy of clinical judgment in neonatal jaundice. Arch Pediatr Adolesc Med. 2000;154:391–394
Davidson LT, Merritt KK, Weech AA. Hyperbilirubinemia in the newborn. Am J Dis Child. 1941;61:958–980
Tayaba R, Gribetz D, Gribetz I, Holzman IR. Noninvasive estimation of serum bilirubin. Pediatrics. 1998;102(3). Available at: www.pediatrics.org/cgi/content/full/102/3/e28
Bhutani V, Gourley GR, Adler S, Kreamer B, Dalman C, Johnson LH. Noninvasive measurement of total serum bilirubin in a multiracial predischarge newborn population to assess the risk of severe hyperbilirubinemia. Pediatrics. 2000;106(2). Available at: www.pediatrics.org/cgi/content/full/106/2/e17
Yasuda S, Itoh S, Isobe K, et al. New transcutaneous jaundice device with two optical paths. J Perinat Med. 2003;31:81–88
Maisels MJ, Ostrea EJ Jr, Touch S, et al. Evaluation of a new transcutaneous bilirubinometer. Pediatrics. 2004;113:1638–1645
Ebbesen F, Rasmussen LM, Wimberley PD. A new transcutaneous bilirubinometer, bilicheck, used in the neonatal intensive care unit and the maternity ward. Acta Paediatr. 2002;91:203–211
Rubaltelli FF, Gourley GR, Loskamp N, et al. Transcutaneous bilirubin measurement: a multicenter evaluation of a new device. Pediatrics. 2001;107:1264–1271
Newman TB, Liljestrand P, Escobar GJ. Jaundice noted in the first 24 hours after birth in a managed care organization. Arch Pediatr Adolesc Med. 2002;156:1244–1250
Bhutani VK, Johnson L, Sivieri EM. Predictive ability of a predischarge hour-specific serum bilirubin for subsequent significant hyperbilirubinemia in healthy term and near-term newborns. Pediatrics. 1999;103:6–14
Garcia FJ, Nager AL. Jaundice as an early diagnostic sign of urinary tract infection in infancy. Pediatrics. 2002;109:846–851
Kaplan M, Hammerman C. Severe neonatal hyperbilirubinemia: a potential complication of glucose-6-phosphate dehydrogenase deficiency. Clin Perinatol. 1998;25:575–590
Valaes T. Severe neonatal jaundice associated with glucose-6-phosphate dehydrogenase deficiency: pathogenesis and global epidemiology. Acta Paediatr Suppl. 1994;394:58–76
Alpay F, Sarici S, Tosuncuk HD, Serdar MA, Inanç N, Gökçay E. The value of first-day bilirubin measurement in predicting the development of significant hyperbilirubinemia in healthy term newborns. Pediatrics. 2000;106(2). Available at: www.pediatrics.org/cgi/content/full/106/2/e16
Carbonell X, Botet F, Figueras J, Riu-Godo A. Prediction of hyperbilirubinaemia in the healthy term newborn. Acta Paediatr. 2001;90:166–170
Kaplan M, Hammerman C, Feldman R, Brisk R. Predischarge bilirubin screening in glucose-6-phosphate dehydrogenase-deficient neonates. Pediatrics. 2000;105:533–537
Stevenson DK, Fanaroff AA, Maisels MJ, et al. Prediction of hyperbilirubinemia in near-term and term infants. Pediatrics. 2001;108:31–39
Newman TB, Xiong B, Gonzales VM, Escobar GJ. Prediction and prevention of extreme neonatal hyperbilirubinemia in a mature health maintenance organization. Arch Pediatr Adolesc Med. 2000;154:1140–1147
Maisels MJ, Kring EA. Length of stay, jaundice, and hospital readmission. Pediatrics. 1998;101:995–998
Gale R, Seidman DS, Dollberg S, Stevenson DK. Epidemiology of neonatal jaundice in the Jerusalem population. J Pediatr Gastroenterol Nutr. 1990;10:82–86
Berk MA, Mimouni F, Miodovnik M, Hertzberg V, Valuck J. Macrosomia in infants of insulin-dependent diabetic mothers. Pediatrics. 1989;83:1029–1034
Peevy KJ, Landaw SA, Gross SJ. Hyperbilirubinemia in infants of diabetic mothers. Pediatrics. 1980;66:417–419
Soskolne El, Schumacher R, Fyock C, Young ML, Schork A. The effect of early discharge and other factors on readmission rates of newborns. Arch Pediatr Adolesc Med. 1996;150:373–379
Ebbesen F, Brodersen R. Risk of bilirubin acid precipitation in preterm infants with respiratory distress syndrome: considerations of blood/brain bilirubin transfer equilibrium. Early Hum Dev. 1982;6:341–355
Cashore WJ, Oh W, Brodersen R. Reserve albumin and bilirubin toxicity index in infant serum. Acta Paediatr Scand. 1983;72:415–419
Cashore WJ. Free bilirubin concentrations and bilirubin-binding affinity in term and preterm infants. J Pediatr. 1980;96:521–527
Wennberg RP. Cellular basis of bilirubin toxicity. N Y State J Med. 1991;91:493–496
Eggert P, Stick C, Schroder H. On the distribution of irradiation intensity in phototherapy. Measurements of effective irradiance in an incubator. Eur J Pediatr. 1984;142:58–61
American Association of Blood Banks Technical Manual Committee. Perinatal issues in transfusion practice. In: Brecher M, ed. Technical Manual. Bethesda, MD: American Association of Blood Banks; 2002:497–515
Garland JS, Alex C, Deacon JS, Raab K. Treatment of infants with indirect hyperbilirubinemia. Readmission to birth hospital vs nonbirth hospital. Arch Pediatr Adolesc Med. 1994;148:1317–1321
Gottstein R, Cooke R. Systematic review of intravenous immunoglobulin in haemolytic disease of the newborn. Arch Dis Child Fetal Neonatal Ed. 2003;88:F6–F10
Sato K, Hara T, Kondo T, Iwao H, Honda S, Ueda K. High-dose intravenous gammaglobulin therapy for neonatal immune haemolytic jaundice due to blood group incompatibility. Acta Paediatr Scand. 1991;80:163–166
Rubo J, Albrecht K, Lasch P, et al. High-dose intravenous immune globulin therapy for hyperbilirubinemia caused by Rh hemolytic disease. J Pediatr. 1992;121:93–97
Hammerman C, Kaplan M, Vreman HJ, Stevenson DK. Intravenous immune globulin in neonatal ABO isoimmunization: factors associated with clinical efficacy. Biol Neonate. 1996;70:69–74
Johnson L, Boggs TR. Bilirubin-dependent brain damage: incidence and indications for treatment. In: Odell GB, Schaffer R, Simopoulos AP, eds. Phototherapy in the Newborn: An Overview. Washington, DC: National Academy of Sciences; 1974:122–149
Ozmert E, Erdem G, Topcu M. Long-term follow-up of indirect hyperbilirubinemia in full-term Turkish infants. Acta Paediatr. 1996;85:1440–1444
Volpe JJ. Neurology of the Newborn. 4th ed. Philadelphia, PA: W. B. Saunders; 2001
Harris M, Bernbaum J, Polin J, Zimmerman R, Polin RA. Developmental follow-up of breastfed term and near-term infants with marked hyperbilirubinemia. Pediatrics. 2001;107:1075–1080
Osborn LM, Bolus R. Breast feeding and jaundice in the first week of life. J Fam Pract. 1985;20:475–480
Martinez JC, Maisels MJ, Otheguy L, et al. Hyperbilirubinemia in the breast-fed newborn: a controlled trial of four interventions. Pediatrics. 1993;91:470–473
Amato M, Howald H, von Muralt G. Interruption of breast-feeding versus phototherapy as treatment of hyperbilirubinemia in full-term infants. Helv Paediatr Acta. 1985;40:127–131
Maisels MJ, Gifford K, Antle CE, Leib GR. Jaundice in the healthy newborn infant: a new approach to an old problem. Pediatrics. 1988;81:505–511
Newman TB, Easterling MJ. Yield of reticulocyte counts and blood smears in term infants. Clin Pediatr (Phila). 1994;33:71–76
Herschel M, Karrison T, Wen M, Caldarelli L, Baron B. Evaluation of the direct antiglobulin (Coombs’) test for identifying newborns at risk for hemolysis as determined by end-tidal carbon monoxide concentration (ETCOc); and comparison of the Coombs’ test with ETCOc for detecting significant jaundice. J Perinatol. 2002;22:341–347
Stevenson DK, Vreman HJ. Carbon monoxide and bilirubin production in neonates. Pediatrics. 1997;100:252–254
Vreman HJ, Verter J, Oh W, et al. Interlaboratory variability of bilirubin measurements. Clin Chem. 1996;42:869–873
Lo S, Doumas BT, Ashwood E. Performance of bilirubin determinations in US laboratories—revisited. Clin Chem. 2004;50:190–194
Kappas A, Drummond GS, Henschke C, Valaes T. Direct comparison of Sn-mesoporphyrin, an inhibitor of bilirubin production, and phototherapy in controlling hyperbilirubinemia in term and near-term newborns. Pediatrics. 1995;95:468–474
Martinez JC, Garcia HO, Otheguy L, Drummond GS, Kappas A. Control of severe hyperbilirubinemia in full-term newborns with the inhibitor of bilirubin production Sn-mesoporphyrin. Pediatrics. 1999;103:1–5
Suresh G, Martin CL, Soll R. Metalloporphyrins for treatment of unconjugated hyperbilirubinemia in neonates. Cochrane Database Syst Rev. 2003;2:CD004207
Kappas A, Drummond GS, Munson DP, Marshall JR. Sn-mesoporphyrin interdiction of severe hyperbilirubinemia in Jehovah’s Witness newborns as an alternative to exchange transfusion. Pediatrics. 2001;108:1374–1377
American Academy of Pediatrics, Steering Committee on Quality Improvement and Management. Classification of recommendations for clinical practice guidelines. Pediatrics. 2004; In press
Johnson LH, Bhutani VK, Brown AK. System-based approach to management of neonatal jaundice and prevention of kernicterus. J Pediatr. 2002;140:396–403
Volpe JJ. Neurology of the Newborn. 4th ed. Philadelphia, PA: W. B. Saunders; 2001
Harris M, Bernbaum J, Polin J, Zimmerman R, Polin RA. Developmental follow-up of breastfed term and near-term infants with marked hyperbilirubinemia. Pediatrics. 2001;107:1075–1080
Jones MH, Sands R, Hyman CB, Sturgeon P, Koch FP. Longitudinal study of incidence of central nervous system damage following erythroblastosis fetalis. Pediatrics. 1954;14:346–350
Moyer VA, Ahn C, Sneed S. Accuracy of clinical judgment in neonatal jaundice. Arch Pediatr Adolesc Med. 2000;154:391–394
Davidson LT, Merritt KK, Weech AA. Hyperbilirubinemia in the newborn. Am J Dis Child. 1941;61:958–980
Tayaba R, Gribetz D, Gribetz I, Holzman IR. Noninvasive estimation of serum bilirubin. Pediatrics. 1998;102(3). Available at: www.pediatrics.org/cgi/content/full/102/3/e28
Maisels MJ, Kring E. Transcutaneous bilirubinometry decreases the need for serum bilirubin measurements and saves money. Pediatrics. 1997;99:599–601
Ip S, Glicken S, Kulig J, Obrien R, Sege R, Lau J. Management of Neonatal Hyperbilirubinemia. Rockville, MD: US Department of Health and Human Services, Agency for Healthcare Research and Quality; 2003. AHRQ Publication 03-E011
Bhutani V, Gourley GR, Adler S, Kreamer B, Dalman C, Johnson LH. Noninvasive measurement of total serum bilirubin in a multiracial predischarge newborn population to assess the risk of severe hyperbilirubinemia. Pediatrics. 2000;106(2). Available at: www.pediatrics.org/cgi/content/full/106/2/e17
Yasuda S, Itoh S, Isobe K, et al. New transcutaneous jaundice device with two optical paths. J Perinat Med. 2003;31:81–88
Maisels MJ, Ostrea EJ Jr, Touch S, et al. Evaluation of a new transcutaneous bilirubinometer. Pediatrics. 2004;113:1638–1645
Ebbesen F, Rasmussen LM, Wimberley PD. A new transcutaneous bilirubinometer, bilicheck, used in the neonatal intensive care unit and the maternity ward. Acta Paediatr. 2002;91:203–211
Rubaltelli FF, Gourley GR, Loskamp N, et al. Transcutaneous bilirubin measurement: a multicenter evaluation of a new device. Pediatrics. 2001;107:1264–1271
Engle WD, Jackson GL, Sendelbach D, Manning D, Frawley W. Assessment of a transcutaneous device in the evaluation of neonatal hyperbilirubinemia in a primarily Hispanic population. Pediatrics. 2002;110:61–67
Schumacher R. Transcutaneous bilirubinometry and diagnostic tests: “the right job for the tool.” Pediatrics. 2002;110:407–408
Vreman HJ, Verter J, Oh W, et al. Interlaboratory variability of bilirubin measurements. Clin Chem. 1996;42:869–873
Doumas BT, Eckfeldt JH. Errors in measurement of total bilirubin: a perennial problem. Clin Chem. 1996;42:845–848
Lo S, Doumas BT, Ashwood E. Performance of bilirubin determinations in US laboratories—revisited. Clin Chem. 2004;50:190–194
Ip S, Chung M, Kulig J. et al. An evidence-based review of important issues concerning neonatal hyperbilirubinemia. Pediatrics. 2004;113(6). Available at: www.pediatrics.org/cgi/content/full/113/6/e644
Leslie GI, Philips JB, Cassady G. Capillary and venous bilirubin values: are they really different?Am J Dis Child. 1987;141:1199–1200
Eidelman AI, Schimmel MS, Algur N, Eylath U. Capillary and venous bilirubin values: they are different—and how [letter]!Am J Dis Child. 1989;143:642
Watkinson LR, St John A, Penberthy LA. Investigation into paediatric bilirubin analyses in Australia and New Zealand. J Clin Pathol. 1982;35:52–58
Bertini G, Dani C, Trochin M, Rubaltelli F. Is breastfeeding really favoring early neonatal jaundice?Pediatrics. 2001;107(3). Available at: www.pediatrics.org/cgi/content/full/107/3/e41
De Carvalho M, Klaus MH, Merkatz RB. Frequency of breastfeeding and serum bilirubin concentration. Am J Dis Child. 1982;136:737–738
De Carvalho M, Holl M, Harvey D. Effects of water supplementation on physiological jaundice in breast-fed babies. Arch Dis Child. 1981;56:568–569
Nicoll A, Ginsburg R, Tripp JH. Supplementary feeding and jaundice in newborns. Acta Paediatr Scand. 1982;71:759–761
Butler DA, MacMillan JP. Relationship of breast feeding and weight loss to jaundice in the newborn period: review of the literature and results of a study. Cleve Clin Q. 1983;50:263–268
De Carvalho M, Robertson S, Klaus M. Fecal bilirubin excretion and serum bilirubin concentration in breast-fed and bottle-fed infants. J Pediatr. 1985;107:786–790
Gourley GR, Kreamer B, Arend R. The effect of diet on feces and jaundice during the first three weeks of life. Gastroenterology. 1992;103:660–667
Laing IA, Wong CM. Hypernatraemia in the first few days: is the incidence rising?Arch Dis Child Fetal Neonatal Ed. 2002;87:F158–F162
Lawrence RA. Management of the mother-infant nursing couple. In: A Breastfeeding Guide for the Medical Profession. 4th ed. St Louis, MO: Mosby-Year Book, Inc; 1994:215-277
Maisels MJ, Newman TB. Predicting hyperbilirubinemia in newborns: the importance of timing. Pediatrics. 1999;103:493–495
Bhutani VK, Johnson L, Sivieri EM. Predictive ability of a predischarge hour-specific serum bilirubin for subsequent significant hyperbilirubinemia in healthy term and near-term newborns. Pediatrics. 1999;103:6–14
Linn S, Schoenbaum SC, Monson RR, Rosner B, Stubblefield PG, Ryan KJ. Epidemiology of neonatal hyperbilirubinemia. Pediatrics. 1985;75:770–774
Newman TB, Easterling MJ, Goldman ES, Stevenson DK. Laboratory evaluation of jaundiced newborns: frequency, cost and yield. Am J Dis Child. 1990;144:364–368
Martinez JC, Maisels MJ, Otheguy L, et al. Hyperbilirubinemia in the breast-fed newborn: a controlled trial of four interventions. Pediatrics. 1993;91:470–473
Brown AK, Kim MH, Wu PY, Bryla DA. Efficacy of phototherapy in prevention and management of neonatal hyperbilirubinemia. Pediatrics. 1985;75:393–400
Armitage P, Mollison PL. Further analysis of controlled trials of treatment of hemolytic disease of the newborn. J Obstet Gynaecol Br Emp. 1953;60:602–605
Mollison PL, Walker W. Controlled trials of the treatment of haemolytic disease of the newborn. Lancet. 1952;1:429–433
Hsia DYY, Allen FH, Gellis SS, Diamond LK. Erythroblastosis fetalis. VIII. Studies of serum bilirubin in relation to kernicterus. N Engl J Med. 1952;247:668–671
Newman TB, Maisels MJ. Does hyperbilirubinemia damage the brain of healthy full-term infants?Clin Perinatol. 1990;17:331–358
Ozmert E, Erdem G, Topcu M. Long-term follow-up of indirect hyperbilirubinemia in full-term Turkish infants. Acta Paediatr. 1996;85:1440–1444
Perlman JM, Rogers B, Burns D. Kernicterus findings at autopsy in 2 sick near-term infants. Pediatrics. 1997;99:612–615
Gartner LM, Snyder RN, Chabon RS, Bernstein J. Kernicterus: high incidence in premature infants with low serum bilirubin concentration. Pediatrics. 1970;45:906–917
Watchko JF, Oski FA. Kernicterus in preterm newborns: past, present, and future. Pediatrics. 1992;90:707–715
Watchko J, Claassen D. Kernicterus in premature infants: current prevalence and relationship to NICHD Phototherapy Study exchange criteria. Pediatrics. 1994;93(6 Pt 1):996–999
Turkel SB, Guttenberg ME, Moynes DR, Hodgman JE. Lack of identifiable risk factors for kernicterus. Pediatrics. 1980;66:502–506
Kim MH, Yoon JJ, Sher J, Brown AK. Lack of predictive indices in kernicterus. A comparison of clinical and pathologic factors in infants with or without kernicterus. Pediatrics. 1980;66:852–858
Newman TB, Xiong B, Gonzales VM, Escobar GJ. Prediction and prevention of extreme neonatal hyperbilirubinemia in a mature health maintenance organization. Arch Pediatr Adolesc Med. 2000;154:1140–1147
Newman TB, Escobar GJ, Gonzales VM, Armstrong MA, Gardner MN, Folck BF. Frequency of neonatal bilirubin testing and hyperbilirubinemia in a large health maintenance organization. Pediatrics. 1999;104:1198–1203
Vohr BR. New approaches to assessing the risks of hyperbilirubinemia. Clin Perinatol. 1990;17:293–306
Perlman M, Fainmesser P, Sohmer H, Tamari H, Wax Y, Pevsmer B. Auditory nerve-brainstem evoked responses in hyperbilirubinemic neonates. Pediatrics. 1983;72:658–664
Nakamura H, Takada S, Shimabuku R, Matsuo M, Matsuo T, Negishi H. Auditory and brainstem responses in newborn infants with hyperbilirubinemia. Pediatrics. 1985;75:703–708
Nwaesei CG, Van Aerde J, Boyden M, Perlman M. Changes in auditory brainstem responses in hyperbilirubinemic infants before and after exchange transfusion. Pediatrics. 1984;74:800–803
Wennberg RP, Ahlfors CE, Bickers R, McMurtry CA, Shetter JL. Abnormal auditory brainstem response in a newborn infant with hyperbilirubinemia: improvement with exchange transfusion. J Pediatr. 1982;100:624–626
Soorani-Lunsing I, Woltil H, Hadders-Algra M. Are moderate degrees of hyperbilirubinemia in healthy term neonates really safe for the brain?Pediatr Res. 2001;50:701–705
Grimmer I, Berger-Jones K, Buhrer C, Brandl U, Obladen M. Late neurological sequelae of non-hemolytic hyperbilirubinemia of healthy term neonates. Acta Paediatr. 1999;88:661–663
Seidman DS, Paz I, Stevenson DK, Laor A, Danon YL, Gale R. Neonatal hyperbilirubinemia and physical and cognitive performance at 17 years of age. Pediatrics. 1991;88:828–833
Newman TB, Klebanoff MA. Neonatal hyperbilirubinemia and long-term outcome: another look at the collaborative perinatal project. Pediatrics. 1993;92:651–657
Scheidt PC, Bryla DA, Nelson KB, Hirtz DG, Hoffman HJ. Phototherapy for neonatal hyperbilirubinemia: six-year follow-up of the National Institute of Child Health and Human Development clinical trial. Pediatrics. 1990;85:455–463
Scheidt PC, Graubard BI, Nelson KB, et al. Intelligence at six years in relation to neonatal bilirubin levels: follow-up of the National Institute of Child Health and Human Development Clinical Trial of Phototherapy. Pediatrics. 1991;87:797–805
Seidman DS, Paz I, Stevenson DK, Laor A, Danon YL, Gale R. Effect of phototherapy for neonatal jaundice on cognitive performance. J Perinatol. 1994;14:23–28
Keenan WJ, Novak KK, Sutherland JM, Bryla DA, Fetterly KL. Morbidity and mortality associated with exchange transfusion. Pediatrics. 1985;75:417–421
Hovi L, Siimes MA. Exchange transfusion with fresh heparinized blood is a safe procedure: Experiences from 1069 newborns. Acta Paediatr Scand. 1985;74:360–365
Jackson JC. Adverse events associated with exchange transfusion in healthy and ill newborns. Pediatrics. 1997;99(5):e7. Available at: www.pediatrics.org/cgi/content/full/99/5/e7
Schreiber GB, Busch MP, Kleinman SH, Korelitz JJ. The risk of transfusion-transmitted viral infections. N Engl J Med. 1996;334:1685–1690
Maisels MJ, Newman TB. Kernicterus in otherwise healthy, breast-fed term newborns. Pediatrics. 1995;96:730–733
Cashore WJ, Oh W. Unbound bilirubin and kernicterus in low-birth-weight infants. Pediatrics. 1982;69:481–485
Nakamura H, Yonetani M, Uetani Y, Funato M, Lee Y. Determination of serum unbound bilirubin for prediction of kernicterus in low birthweight infants. Acta Paediatr Jpn. 1992;34:642–647
Funato M, Tamai H, Shimada S, Nakamura H. Vigintiphobia, unbound bilirubin, and auditory brainstem responses. Pediatrics. 1994;93:50–53
Amin SB, Ahlfors CE, Orlando MS, Dalzell LE, Merle KS, Guillet R. Bilirubin and serial auditory brainstem responses in premature infants. Pediatrics. 2001;107:664–670
Johnson L, Boggs TR. Bilirubin-dependent brain damage: incidence and indications for treatment. In: Odell GB, Schaffer R, Simopoulos AP, eds. Phototherapy in the Newborn: An Overview. Washington, DC: National Academy of Sciences; 1974:122–149
Odell GB, Storey GNB, Rosenberg LA. Studies in kernicterus. 3. The saturation of serum proteins with bilirubin during neonatal life and its relationship to brain damage at five years. J Pediatr. 1970;76:12–21
Cashore WJ. Free bilirubin concentrations and bilirubin-binding affinity in term and preterm infants. J Pediatr. 1980;96:521–527
Ebbesen F, Brodersen R. Risk of bilirubin acid precipitation in preterm infants with respiratory distress syndrome: considerations of blood/brain bilirubin transfer equilibrium. Early Hum Dev. 1982;6:341–355
Cashore WJ, Oh W, Brodersen R. Reserve albumin and bilirubin toxicity index in infant serum. Acta Paediatr Scand. 1983;72:415–419
Ebbesen F, Nyboe J. Postnatal changes in the ability of plasma albumin to bind bilirubin. Acta Paediatr Scand. 1983;72:665–670
Esbjorner E. Albumin binding properties in relation to bilirubin and albumin concentrations during the first week of life. Acta Paediatr Scand. 1991;80:400–405
Robertson A, Sharp C, Karp W. The relationship of gestational age to reserve albumin concentration for binding of bilirubin. J Perinatol. 1988;8:17–18
Wennberg RP. Cellular basis of bilirubin toxicity. N Y State J Med. 1991;91:493–496
Fiberoptic phototherapy systems. Health Devices. 1995;24:132–153
International Electrotechnical Commission. Medical electrical equipment—part 2-50: particular requirements for the safety of infant phototherapy equipment. 2000. IEC 60601-2-50. Available at www.iec.ch. Accessed June 7, 2004
Tan KL. The pattern of bilirubin response to phototherapy for neonatal hyperbilirubinemia. Pediatr Res. 1982;16:670–674
Seidman DS, Moise J, Ergaz Z, et al. A new blue light-emitting phototherapy device: a prospective randomized controlled study. J Pediatr. 2000;136:771–774
Ennever JF. Blue light, green light, white light, more light: treatment of neonatal jaundice. Clin Perinatol. 1990;17:467–481
Garg AK, Prasad RS, Hifzi IA. A controlled trial of high-intensity double-surface phototherapy on a fluid bed versus conventional phototherapy in neonatal jaundice. Pediatrics. 1995;95:914–916
Eggert P, Stick C, Schroder H. On the distribution of irradiation intensity in phototherapy. Measurements of effective irradiance in an incubator. Eur J Pediatr. 1984;142:58–61
Hansen TW. Acute management of extreme neonatal jaundice—the potential benefits of intensified phototherapy and interruption of enterohepatic bilirubin circulation. Acta Paediatr. 1997;86:843–846
Newman TB, Liljestrand P, Escobar GJ. Infants with bilirubin levels of 30 mg/dL or more in a large managed care organization. Pediatrics. 2003;111(6 Pt 1):1303–1311
Maisels MJ, Kring E. Bilirubin rebound following intensive phototherapy. Arch Pediatr Adolesc Med. 2002;156:669–672
Tan KL. Comparison of the efficacy of fiberoptic and conventional phototherapy for neonatal hyperbilirubinemia. J Pediatr. 1994;125:607–612
Rubaltelli FF, Zanardo V, Granati B. Effect of various phototherapy regimens on bilirubin decrement. Pediatrics. 1978;61:838–841
Maurer HM, Shumway CN, Draper DA, Hossaini AA. Controlled trial comparing agar, intermittent phototherapy, and continuous phototherapy for reducing neonatal hyperbilirubinemia. J Pediatr. 1973;82:73–76
Lau SP, Fung KP. Serum bilirubin kinetics in intermittent phototherapy of physiological jaundice. Arch Dis Child. 1984;59:892–894
McDonagh AF, Lightner DA. ‘Like a shrivelled blood orange’—bilirubin, jaundice, and phototherapy. Pediatrics. 1985;75:443–455
Yetman RJ, Parks DK, Huseby V, Mistry K, Garcia J. Rebound bilirubin levels in infants receiving phototherapy. J Pediatr. 1998;133:705–707
Lazar L, Litwin A, Merlob P. Phototherapy for neonatal nonhemolytic hyperbilirubinemia. Analysis of rebound and indications for discontinuing therapy. Clin Pediatr (Phila). 1993;32:264–267
Cremer RJ, Perryman PW, Richards DH. Influence of light on the hyperbilirubinemia of infants. Lancet. 1958;1(7030):1094–1097
Rubaltelli FF, Jori G, Reddi E. Bronze baby syndrome: a new porphyrin-related disorder. Pediatr Res. 1983;17:327–330
Meisel P, Jahrig D, Theel L, Ordt A, Jahrig K. The bronze baby syndrome: consequence of impaired excretion of photobilirubin?Photobiochem Photobiophys. 1982;3:345–352
Mallon E, Wojnarowska F, Hope P, Elder G. Neonatal bullous eruption as a result of transient porphyrinemia in a premature infant with hemolytic disease of the newborn. J Am Acad Dermatol. 1995;33:333–336
Paller AS, Eramo LR, Farrell EE, Millard DD, Honig PJ, Cunningham BB. Purpuric phototherapy-induced eruption in transfused neonates: relation to transient porphyrinemia. Pediatrics. 1997;100:360–364
Tonz O, Vogt J, Filippini L, Simmler F, Wachsmuth ED, Winterhalter KH. Severe light dermatosis following phototherapy in a newborn infant with congenital erythropoietic urophyria [in German]. Helv Paediatr Acta. 1975;30:47–56
Soylu A, Kavukcu S, Turkmen M. Phototherapy sequela in a child with congenital erythropoietic porphyria. Eur J Pediatr. 1999;158:526–527